NCT06225661

Brief Summary

Suicide is the leading cause of death due to illness among Canadian youth, claiming more lives than any medical illness, including cancer. Suicide prevention is possible, and early intervention is needed. The investigators will examine the effectiveness of a previously-piloted, ED-based suicide prevention intervention, across Canadian sites, using a randomized clinical trial design. The investigators will determine whether the patient- and family-centered intervention is more effective than enhanced usual care in reducing suicide-related behaviors in 330 youth at high-risk of suicide.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
330

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

4.8 years

First QC Date

January 11, 2024

Last Update Submit

September 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Suicide Risk Events (SREs) throughout 6 months of study engagement

    Suicide attempts and unscheduled ED/hospital re-visits (including hospitalization) for SREs, or death by suicide during the 6-month follow up period. SREs will be determined by participant and caregiver report using validated questions regarding suicide attempts from the Columbia-Suicide Severity Rating Scale (C-SSRS).

    Baseline, 6 weeks, 24 weeks

Secondary Outcomes (10)

  • Columbia-Suicide Severity Rating Scale (C-SSRS)

    Baseline, 6 weeks, 24 weeks

  • Suicidal Ideation Questionnaire-Jr (SIQ-Jr)

    Baseline, 6 weeks, 24 weeks

  • Schedule for Affective Disorders and Schizophrenia Depression Rating Scale (KSADS-DEPc)

    Baseline, 6 weeks, 24 weeks

  • Screen for Child Anxiety Related Disorders (SCARED)

    Baseline, 6 weeks, 24 weeks

  • Centre for Epidemiological Studies Depression Scale for Children (CES-DC)

    Baseline, 6 weeks, 24 weeks

  • +5 more secondary outcomes

Study Arms (2)

SAFE Intervention

EXPERIMENTAL

This group will receive the SAFE individual youth and family-based intervention.

Behavioral: SAFE Intervention

NAV (Telephone Navigation)

ACTIVE COMPARATOR

This group will receive telephone-based case navigation.

Behavioral: NAV (Telephone Navigation)

Interventions

Manualized individual youth and family psychotherapeutic intervention. Weekly individual and family sessions with a therapist for 6 weeks. Participants will continue to receive usual care.

SAFE Intervention

Weekly telephone contact with parents regarding participant health care utilization. Referrals to community mental health resources provided as needed. Participants will continue to receive usual care.

NAV (Telephone Navigation)

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Youth presenting in the Emergency Department with SIQ-Jr score ≥ 31,
  • Has a participating parent or caregiver who is able to communicate easily in English, or is willing to communicate using a hospital-organized translator,
  • Between the ages 12-17 years old,
  • Living in the catchment area of one of the three hospital sites and access to a telephone.

You may not qualify if:

  • Score of 3 on KSADS screen for current psychosis or elevated mood
  • Moderate to severe intellectual disability, and/or autism based on clinical chart.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Alberta Children's Hospital - Alberta Health Services & University of Calgary

Calgary, Alberta, T2W 1S7, Canada

Location

McMaster Children's Hospital - Hamilton Health Sciences

Hamilton, Ontario, L8L 8E7, Canada

Location

Trillium Health Partners

Mississauga, Ontario, L5B 1B8, Canada

Location

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

MeSH Terms

Conditions

SuicideSuicide PreventionSuicidal IdeationSelf-Injurious BehaviorBehavioral SymptomsSuicide, Attempted

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study investigators and outcome assessors are blinded to allocation assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Scientist

Study Record Dates

First Submitted

January 11, 2024

First Posted

January 26, 2024

Study Start

March 1, 2021

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations